Security National Trust Co. Buys 160 Shares of Thermo Fisher Scientific Inc. (TMO)

Security National Trust Co. increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 19,923 shares of the medical research company’s stock after purchasing an additional 160 shares during the quarter. Thermo Fisher Scientific accounts for 1.7% of Security National Trust Co.’s portfolio, making the stock its 10th largest position. Security National Trust Co.’s holdings in Thermo Fisher Scientific were worth $5,453,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of TMO. CX Institutional bought a new stake in Thermo Fisher Scientific in the 1st quarter valued at $36,000. Freestone Capital Holdings LLC increased its holdings in shares of Thermo Fisher Scientific by 46.1% in the 4th quarter. Freestone Capital Holdings LLC now owns 10,081 shares of the medical research company’s stock worth $2,256,000 after buying an additional 3,180 shares during the last quarter. Putnam FL Investment Management Co. increased its holdings in shares of Thermo Fisher Scientific by 2.9% in the 4th quarter. Putnam FL Investment Management Co. now owns 29,001 shares of the medical research company’s stock worth $6,490,000 after buying an additional 810 shares during the last quarter. Steinberg Global Asset Management increased its holdings in shares of Thermo Fisher Scientific by 21.1% in the 1st quarter. Steinberg Global Asset Management now owns 5,747 shares of the medical research company’s stock worth $1,187,000 after buying an additional 1,000 shares during the last quarter. Finally, Calamos Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 5.4% in the 4th quarter. Calamos Advisors LLC now owns 132,462 shares of the medical research company’s stock worth $29,644,000 after buying an additional 6,769 shares during the last quarter. Institutional investors own 88.39% of the company’s stock.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,713 shares of the business’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $273.21, for a total value of $13,855,298.73. Following the completion of the sale, the chief executive officer now directly owns 302,193 shares of the company’s stock, valued at approximately $82,562,149.53. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Gregory J. Herrema sold 19,808 shares of the business’s stock in a transaction dated Monday, February 25th. The shares were sold at an average price of $253.29, for a total transaction of $5,017,168.32. Following the completion of the sale, the senior vice president now owns 25,688 shares of the company’s stock, valued at approximately $6,506,513.52. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,320 shares of company stock valued at $20,405,269. 0.45% of the stock is owned by corporate insiders.

Thermo Fisher Scientific stock traded up $6.30 during trading hours on Wednesday, hitting $271.66. The company had a trading volume of 1,691,985 shares, compared to its average volume of 1,676,784. The stock has a market cap of $105.16 billion, a price-to-earnings ratio of 24.43, a price-to-earnings-growth ratio of 1.72 and a beta of 1.11. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.69 and a quick ratio of 1.16. Thermo Fisher Scientific Inc. has a 1 year low of $202.83 and a 1 year high of $282.98.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, April 24th. The medical research company reported $2.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.74 by $0.07. The company had revenue of $6.13 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Thermo Fisher Scientific had a net margin of 12.89% and a return on equity of 17.06%. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $2.50 EPS. Research analysts expect that Thermo Fisher Scientific Inc. will post 12.19 earnings per share for the current year.

TMO has been the topic of a number of research reports. BTIG Research boosted their target price on shares of Thermo Fisher Scientific to $290.00 and gave the stock a “buy” rating in a report on Thursday, January 31st. Robert W. Baird lifted their price target on shares of Thermo Fisher Scientific from $264.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. Barclays lifted their price target on shares of Thermo Fisher Scientific from $295.00 to $300.00 and gave the stock an “overweight” rating in a research note on Monday, March 18th. Deutsche Bank lifted their price target on shares of Thermo Fisher Scientific from $275.00 to $300.00 and gave the stock a “buy” rating in a research note on Friday, March 22nd. Finally, UBS Group lifted their price target on shares of Thermo Fisher Scientific to $305.00 and gave the stock a “buy” rating in a research note on Monday, March 25th. Two research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $293.77.

COPYRIGHT VIOLATION WARNING: “Security National Trust Co. Buys 160 Shares of Thermo Fisher Scientific Inc. (TMO)” was originally reported by Sundance Herald and is owned by of Sundance Herald. If you are reading this report on another domain, it was stolen and republished in violation of U.S. and international copyright & trademark law. The original version of this report can be accessed at https://sundanceherald.com/2019/05/22/security-national-trust-co-increases-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Return on Investment (ROI)

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply